Literature DB >> 15340032

Critical limb ischaemia associated with chemotherapy for breast cancer.

W V Garrett1, J R I Brown, D Pickering, S M Andrews.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15340032      PMCID： PMC1079594          DOI： 10.1177/014107680409700915

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  7 in total

1.  5-Fluorouracil-induced Raynaud's phenomenon.

Authors:  D Papamichael; N Amft; M L Slevin; D D'Cruz
Journal:  Eur J Cancer       Date:  1998-11       Impact factor: 9.162

2.  Coronary vasospasm as a cause of effort-related myocardial ischemia during low-dose chronic continuous infusion of 5-fluorouracil.

Authors:  C Lestuzzi; E Viel; E Picano; N Meneguzzo
Journal:  Am J Med       Date:  2001-09       Impact factor: 4.965

Review 3.  Cardiotoxicity of the antiproliferative compound fluorouracil.

Authors:  K Becker; J F Erckenbrecht; D Häussinger; T Frieling
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

4.  Clinical cardiotoxicity of 5-fluorouracil.

Authors:  D L Keefe; N Roistacher; M K Pierri
Journal:  J Clin Pharmacol       Date:  1993-11       Impact factor: 3.126

5.  In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle.

Authors:  M Mosseri; H J Fingert; L Varticovski; S Chokshi; J M Isner
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

6.  Effects of probucol on endothelial damage by 5-fluorouracil.

Authors:  Sara Kinhult; Maria Albertsson; Jan Eskilsson; Magdalena Cwikiel
Journal:  Acta Oncol       Date:  2003       Impact factor: 4.089

7.  Prinzmetal's angina during 5-fluorouracil chemotherapy.

Authors:  N S Kleiman; D E Lehane; C E Geyer; C M Pratt; J B Young
Journal:  Am J Med       Date:  1987-03       Impact factor: 4.965
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.